Surveillance schedules, what a visit involves, and lowering your future risk
Bring a printable list of questions to your appointment, or share this page with someone who needs it.
Successfully treating a squamous cell carcinoma (SCC) is not the end of the story. Because most recurrences and nodal metastases happen within the first two years, and because having one SCC significantly raises the odds of developing another skin cancer, ongoing follow-up is a core part of your care — not an optional extra.
This guide walks through how often you'll need to be seen based on your tumor's risk category, what actually happens at a follow-up visit, what the data says about your long-term risk, and what you can do between visits to lower it.
How closely you're monitored after treatment depends heavily on whether your SCC was classified as low-risk or high-risk — a distinction based on factors like size, depth, location, and differentiation. See our guide to staging and grading for how that classification is determined, and to recurrence and metastasis risk for the specific features that push a tumor into the high-risk group.
NCCN guidelines generally recommend a full skin exam every 6-12 months for the first several years after treatment, then transitioning to an annual exam once you've remained clear for a period your dermatologist determines. Low-risk tumors have a low recurrence rate, but ongoing checks still matter because of the elevated risk of a new, unrelated skin cancer.
For high-risk tumors, guidelines recommend a more intensive schedule: every 3-6 months for the first 2 years, then spacing out to every 6-12 months through year 5, and annually after that. This tighter early schedule exists because the data consistently shows that the great majority of local recurrences and lymph node metastases occur within that first two-year window — a cohort study following high-risk patients found a median time to nodal metastasis of well under a year among those who developed it. Catching a recurrence or nodal spread early, while it's still treatable, is the entire purpose of this schedule.
One of the most important reasons follow-up doesn't stop after the "high-risk window" closes is that a history of SCC substantially raises your lifetime odds of developing another keratinocyte carcinoma — not necessarily a recurrence of the same tumor, but a brand-new one elsewhere on sun-exposed skin.
A widely cited meta-analysis of patients with a history of nonmelanoma skin cancer found that within 3 years, about 44% developed a subsequent basal cell carcinoma and about 18% developed another squamous cell carcinoma — far above the risk in someone with no prior skin cancer history. That elevated risk is exactly why "you're done" isn't really how SCC treatment ends; ongoing surveillance is treated as part of managing a chronic risk, similar to how other cancer survivors are monitored for new primary tumors.
Between scheduled visits, two things do the most to lower your risk of another SCC.
Broad-spectrum SPF 30+ sunscreen reapplied every two hours outdoors, sun-protective clothing, and avoiding peak UV hours remain the foundation of prevention after any keratinocyte cancer. UV exposure is the dominant driver of SCC risk, and this doesn't change once treatment is finished.
For patients with a strong history of skin cancer, dermatologists sometimes add chemoprevention. Oral nicotinamide (vitamin B3) — an inexpensive, over-the-counter supplement, distinct from niacin — reduced the rate of new SCCs by about 30% and new BCCs by about 20% in a large randomized trial of high-risk, immunocompetent patients, with a favorable safety profile. Oral retinoids are another option used more selectively, particularly in organ transplant recipients or others at very high risk, though they require monitoring for side effects like dry skin, elevated lipids, and liver enzyme changes. Neither is a substitute for sunscreen or your scheduled exams — they're additive tools your dermatologist may discuss if your risk profile warrants it.
Follow-up after SCC treatment isn't a formality — it's built around a well-documented pattern of when recurrences and nodal spread actually happen, which is why high-risk tumors are watched most closely in the first two years. Just as importantly, a history of SCC raises your odds of developing another skin cancer for years to come, which keeps regular skin exams relevant long after any individual tumor is considered cured.
Between visits, sun protection remains your single most effective tool, with chemoprevention as an added option for some high-risk patients. Sticking with your recommended schedule — and learning your own skin well enough to notice changes yourself — gives you and your dermatologist the best chance of catching anything new while it's still easy to treat.
Disclaimer: This article is for educational purposes only and not a substitute for professional medical advice. Your personal follow-up schedule and prevention plan should be determined by your dermatologist based on your specific tumor and risk factors.
Chat with our AI guide for personalized information about follow-up care after SCC
Chat with the Navigator